Latest Breaking News On - Manchester biomedical research centre - Page 4 : comparemela.com

DOT1L gene variants associated with a new neu

<p>A study from the laboratory of Dr. Hugo J. Bellen, a distinguished service professor at Baylor College of Medicine and a principal investigator at the&nbsp;<a href="file:///C:/Users/rxnatara/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/DJZEC7Z1/nri.texaschildrens.org">Jan and Dan Duncan Neurological Research Institute</a>&nbsp;(Duncan NRI) at Texas Children&rsquo;s Hospital, has discovered that gain-of-function variants in the&nbsp;<em>DOT1L&nbsp;</em>gene cause a new disorder. Further studies revealed that the majority of the symptoms in the patients were surprisingly due to an increase in the enzymatic activity of a histone methylase encoded by this gene. This study was published in the&nbsp;<em><u><a href="https://www.cell.com/ajhg/fulltext/S0002-9297(23)00322-1">American Journal of Human Genetics</a></u></em>.</p>

Work starts on £42m lab and office space in boost to city's life sciences credentials

Citylabs 4.0 is expected to open in spring 2025

Manchester Uni Develops First Reliable Dementia Test for Deaf

Hope for the UK clinical trial landscape but it requires a lot of work

The Arena International Outsourcing in Clinical Trials UK and Ireland discussed how the UK’s clinical trial landscape has taken a hit and what improvements are needed to make it a more viable country for research.

UK Safety Mark Awarded to Lifesaving Bedside Stroke Test